Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans

Cited by (329)

Items 101–200 of 329

1. Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression
   Hye Young Kim, Young Hyun Yoo · 2022 · International Journal of Molecular Sciences
2. Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
   Shengyu Zhang, Congcong Shen, Di Han, Yanhong Wang, Feng Guan · 2025 · Antioxidants
3. Innate-like T lymphocytes in chronic liver disease
   Maria Papanastasatou, Mihalis Verykokakis · 2023 · Frontiers in Immunology
4. Impaired hepatic lipid metabolism and biomarkers in fatty liver diseases.
   Francisca S. Teixeira, L. Pimentel, M. E. Pintado, Luis M. Rodríguez-Alcalá · 2023 · Biochimie
5. Prolonged Cold Exposure Negatively Impacts Atlantic Salmon (Salmo salar) Liver Metabolism and Function
   Isis Rojas, Albert Caballero‐Solares, Émile Vadboncoeur, Rebeccah M. Sandrelli, Jennifer R. Hall, Kathy A. Clow, Christopher Charles Parrish, Matthew L. Rise, Andrew K. Swanson, A. Kurt Gamperl · 2024 · Biology
6. Vaccinium spp. Berries in the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Update of Preclinical and Clinical Research
   Ewelina Książek, Zuzanna Goluch, Marta Bochniak · 2024 · Nutrients
7. Ultrasound evaluation of kidney and liver involvement in Bardet–Biedl syndrome
   Metin Cetiner, Ilja Finkelberg, Felix Schiepek, Lars Pape, Raphael Hirtz, Anja Katrin Büscher · 2024 · Orphanet Journal of Rare Diseases
8. Hydroxysteroid 17β‐dehydrogenase 13 ( Hsd17b13 ) knockdown attenuates liver steatosis in high‐fat diet obese mice
   Shehroz Mahmood, Nicola Morrice, Dawn Thompson, Sara Milanizadeh, Sophie Wilson, Phillip D. Whitfield, George D. Mcilroy, Justin J. Rochford, Nimesh Mody · 2025 · Experimental Physiology
9. Nonalcoholic Steatohepatitis Disrupts Diurnal Liver Transcriptome Rhythms in Mice
   Leonardo Vinícius Monteiro de Assis, Münevver Demir, Henrik Oster · 2023 · Cellular and Molecular Gastroenterology and Hepatology
10. Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease
    Jiale Liu, Tao Wang, Fuyuan Yang, Ciren Pubu · 2025 · Frontiers in Endocrinology
11. Gentiopicroside improves high-fat diet-induced NAFLD in association with modulation of host serum metabolome and gut microbiome in mice
    Lijuan Wang, Yuxin Jiang, Qian Yu, Chunping Xiao, Jin Sun, Lili Weng, Ye Qiu · 2023 · Frontiers in Microbiology
12. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity
    Melissa Lopez‐Pentecost, Martha Taméz, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia · 2023 · Nutrients
13. Constitutive androstane receptor, liver pathophysiology and chemical contaminants: current evidence and perspectives
    Francesca De Battistis, Aleksandra Buha Djordjević, Luciano Saso, Alberto Mantovani · 2025 · Frontiers in Endocrinology
14. Electromagnetic fields ameliorate hepatic lipid accumulation and oxidative stress: potential role of CaMKKβ/AMPK/SREBP-1c and Nrf2 pathways
    Mingming Zhai, Chenxu Zhang, Jinxiu Cui, Juan Liu, Yuanzhe Li, Kangning Xie, Erping Luo, Chi Tang · 2023 · BioMedical Engineering OnLine
15. The role and mechanism of pyroptosis and potential therapeutic targets in non-alcoholic fatty liver disease (NAFLD)
    Shu-Jing Li, An-Bu Liu, Yuan-Yuan Yu, Jin-Hai Ma · 2024 · Frontiers in Cell and Developmental Biology
16. Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1
    Fei Zhao, Jinjing Ke, Wensheng Pan, Hanghai Pan, Miao Shen · 2022 · Molecular Medicine
17. Effect of Bergamot Leaves (Citrus bergamia) in the Crosstalk between Adipose Tissue and Liver of Diet-Induced Obese Rats
    Juliana Silva Siqueira, Erika Tiemi Nakandakare-Maia, Taynara Aparecida Vieira, Thiago Luiz Novaga Palacio, Núbia Alves Grandini, Matheus Antônio Filiol Belin, Gisele Alborghetti Nai, Fernando Moreto, Alessandra Altomare, Giovanna Baron et al. · 2023 · Livers
18. Olfactomedin 4 deletion exacerbates nonalcoholic fatty liver disease through P62-dependent mitophagy in mice
    Shenghui Chen, Xinyu Wang, Zhening Liu, Jinghua Wang, Yanjun Guo, Qinqiu Wang, Hangkai Huang, Youming Li, Chaohui Yu, Chengfu Xu · 2023 · Metabolism
19. BMAL1 deletion protects against obesity and non-alcoholic fatty liver disease induced by a high-fat diet
    Chongwen Zhan, Haoran Chen, Zhao Zhang, Yikai Shao, Bo Xu, Rong Hua, Qiyuan Yao, Wenjuan Liu, Qiwei Shen · 2023 · International Journal of Obesity
20. Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow‐up ( DPV) database
    Svenja Meyhöfer, Alexander J. Eckert, Michael Hummel, Markus Wolfgang Laimer, Michael Roden, Stephan Kreß, Jochen Seufert, Sebastian M. Meyhöfer, Reinhard Walter Holl · 2021 · Diabetes Obesity and Metabolism
21. Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides
    Jonas M. McCaffrey, Jamal A. Ibdah · 2025 · Nutrients
22. Lack of GPR180 ameliorates hepatic lipid depot via downregulation of mTORC1 signaling
    Ken Yoshida, Kazuha Yokota, Kazuhisa Watanabe, Hidetoshi Tsuda, Ayumi Matsumoto, Hiroaki Mizukami, Sadahiko Iwamoto · 2023 · Scientific Reports
23. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier
    Xueying Lai, Hong Zhou, Yu Wan, Jiesi Kuang, Yuhui Yang, Limei Mai, Yumei Chen, Bin Liu · 2024 · International Immunopharmacology
24. Circulating small non‐coding RNAs are associated with the insulin‐resistant and obesity‐related type 2 diabetes clusters
    J. A. de Klerk, J. Beulens, R. Bijkerk, A. V. van Zonneveld, P. Elders, L. 't Hart, R. Slieker · 2024 · Diabetes, obesity and metabolism
25. Novel insights into the role of quercetin and kaempferol from Carthamus tinctorius L. in the management of nonalcoholic fatty liver disease via NR1H4-mediated pathways
    Wenxiang Wang, Ce Yang, Jing Xia, Ying Xim Tan, Xiaoyuan Peng, Wei Xiong, Ning Li · 2024 · International Immunopharmacology
26. Exogenous hydrogen sulfide improves non-alcoholic fatty liver disease by inhibiting endoplasmic reticulum stress/NLRP3 inflammasome pathway
    Xiaodi Fu, Qi Zhang, Yuhang Chen, Ying Li, Honggang Wang · 2025 · Molecular and Cellular Biochemistry
27. Association of circulating omentin level and metabolic-associated fatty liver disease: a systematic review and meta-analysis
    Qin Zhang, Shuaihang Chen, Yani Ke, Qicong Li, Chenglu Shen, Yuting Ruan, Kaihan Wu, Jie Hu, Shan Liu · 2023 · Frontiers in Endocrinology
28. Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy
    Farah Khaznadar, Ana Petrovic, Omar Khaznadar, Hrvoje Roguljić, Kristina Bojanić, Lucija Kuna, Stjepan Siber, Robert Smolić, Ines Bilić-Čurčić, George Y. Wu et al. · 2023 · Journal of Clinical Medicine
29. Sex-Specific Association between Sodium Intake Estimated by 24-Hour Urinary Sodium Excretion and Nonalcoholic Fatty Liver Disease: The Community-Based Prospective Cohort Study
    Jihye Lee, Ju‐Yeon Lee, Yun-Jung Yang · 2024 · Nutrients
30. Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases
    Luis Alberto Videla, Rodrigo Valenzuela, Jessica Zúñiga‐Hernández, Andrea del Campo · 2024 · Molecular Nutrition & Food Research
31. Deficiency in Tissue Non-Specific Alkaline Phosphatase Leads to Steatohepatitis in Mice Fed a High Fat Diet Similar to That Produced by a Methionine and Choline Deficient Diet
    Reyes Gámez‐Belmonte, Mireia Tena‐Garitaonaindia, Cristina Hernández‐Chirlaque, Samir Córdova, Diego Ceacero‐Heras, Fermín Sánchez de Medina, Olga Martínez‐Augustin · 2020 · International Journal of Molecular Sciences
32. A UPLC-Q-TOF/MS and network pharmacology method to explore the mechanism of Anhua fuzhuan tea intervention in nonalcoholic fatty liver disease
    Fengming Tian, Jian Yi, Yan Tang, Bowei Chen, Hongping Long, Ying-Fei Liu, Yin Ouyang, Wenjiang Zhang, Tang Rong-mei, Baiyan Liu · 2023 · Food & Function
33. Oxymatrine Alleviates High-Fat-High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through an Untargeted Metabonomics Study
    Huan Li, Chang Wang, Qing Wang, Xuehua Liu, Juanjuan Zhang, He Zhang, Wenjie Fei, Hang Zhao, Luping Ren · 2023 · Diabetes Metabolic Syndrome and Obesity
34. Association between urinary polycyclic aromatic hydrocarbons and risk of metabolic associated fatty liver disease
    Minzhen Wang, Shaoyan Tang, Lulu Zhang, Yamin Zhao, Yindi Peng, Shan Zheng, Zanchao Liu · 2024 · International Archives of Occupational and Environmental Health
35. MAFLD-related hepatocellular carcinoma: Exploring the potent combination of immunotherapy and molecular targeted therapy
    Ziwei Guo, Ziang Yao, Bohao Huang, Dongjie Wu, Yanbo Li, Xiaohan Chen, Yanping Lu, Li Wang, Wenliang Lv · 2024 · International Immunopharmacology
36. Multi-omics reveal the effects and regulatory mechanism of dietary echinocystic acid supplementation on abdominal fat and liver steatosis in broiler chickens
    Lianggui Xiao, Jiazhe Liu, Liangshan Qin, Shan Deng, Guodong Mo, Dandan Zhang, Ben Huang · 2025 · Poultry Science
37. RETRACTED: A nomogram for predicting metabolic-associated fatty liver disease in non-obese newly diagnosed type 2 diabetes patients
    Yuliang Cui, Fenghua Li, Tingting Li, Wanjing Sun, Haiyan Shi, Yunyun Cheng · 2025 · Frontiers in Endocrinology · Retracted
38. The Beneficial Effects of Resveratrol on Hepatocellular Carcinoma and Nonalcoholic Fatty Liver Disease: Modulation of Apoptosis, Autophagy, Inflammation, and Oxidative Stress
    Ziyao Wan, Jamal Hallajzadeh · 2025 · Food Science & Nutrition
39. Physical exercise positively modulates nonalcoholic steatohepatitis‐related hepatic endoplasmic reticulum stress
    Emanuel Passos, Cidália Pereira, Inês Oliveira Gonçalves, Ana Faria, António A.M.R. Ascensão, Rosário Monteiro, José Magalhães, Maria João Martins · 2022 · Journal of Cellular Biochemistry
40. Oleuropein as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease During Hepatitis C
    Mohammadjavad Sotoudeheian, SeyedAhmad Hoseini, Seyed‐Mohamad‐Sadegh Mirahmadi, Navid Farahmandian, Hamidreza Pazoki–Toroudi · 2023 · Revista Brasileira de Farmacognosia
41. Very low-carbohydrate diet with higher protein ratio improves lipid metabolism and inflammation in rats with diet-induced nonalcoholic fatty liver disease
    I-Ting Wu, Wan-Ju Yeh, Wen‐Chih Huang, Hsin‐Yi Yang · 2024 · The Journal of Nutritional Biochemistry
42. Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease
    Jun Cao, Lin Hua, Shipei Zhang, Jinping Tang, Fan Ke, Zhouhuan Wu, Guohui Xue · 2022 · Lipids in Health and Disease
43. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS −/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Begoña Lavín, Thomas R. Eykyn, Alkystis Phinikaridou, Aline Xavier, Shravan Kumar, Xabier Buqué, Patricia Aspichueta, Carlos Sing‐Long, Marco A. Arrese, René Michael Botnar et al. · 2023 · NMR in Biomedicine
44. Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration
    Andrea Peloso, Matthieu Tihy, Beat Moeckli, Laura Rubbia‐Brandt, Christian Toso · 2022 · Nutrients
45. ELOVL1 is upregulated and promotes tumor growth in hepatocellular carcinoma through regulating PI3K-AKT-mTOR signaling
    Liang Qin, Cheng-ze Song, Fa-yang Yuan, Xue-fa Wang, Yang Yang, Yifei Ma, Zili Chen · 2024 · Heliyon
46. Leveraging adrenergic receptor blockade for enhanced nonalcoholic fatty liver disease treatment via a biomimetic nanoplatform
    Bingyuan Fei, Yuewu Zhao, Jine Wang, Panyue Wen, Junjie Li, Masaru Tanaka, Zheng Wang, Shuo Li · 2024 · Journal of Nanobiotechnology
47. Trehalose Ameliorates Nonalcoholic Fatty Liver Disease by Regulating IRE1α–TFEB Signaling Pathway
    Shan Su, Xiaohong Liu, Min Zhu, Wen Liu, Jingyi Liu, Yujia Yuan, Fudong Fu, Zhiyong Rao, Jingping Liu, Yanrong Lu et al. · 2024 · Journal of Agricultural and Food Chemistry
48. “Efficacy of SGLT2 inhibitors in non-diabetic non-alcoholic fatty liver disease: a systematic review and meta-analysis”
    Muhammad Sharjeel Abbas, Mrunalini Dandamudi, Tooba Rehman, Muhammad Aqib Faizan, Izza Zahra, John Cedric Mojica, Maryam Mohammed Ali Ahmed, Karishma Bai, Izza Shakeel, Zunaira Shahzad et al. · 2025 · Journal of Diabetes & Metabolic Disorders
49. Kaempferol alleviates high-fat-induced hepatocyte injury by inhibiting ferroptosis
    Linjie Lou, Ye Ren, Yisheng Huang · 2026 · Tissue and Cell
50. Unravelling the liver-brain connection: A two-sample Mendelian randomization study investigating the causal relationship between NAFLD and cortical structure
    Shitao Jiang, Junwei Zhang, Yaoge Liu, Ting Zhang, Han Zheng, Xinting Sang, Xin Lü, Yiyao Xu · 2023 · Diabetes Research and Clinical Practice
51. Circ_0004535/miR-1827/CASP8 network involved in type 2 diabetes mellitus with nonalcoholic fatty liver disease
    Min Li, Ai Zeng, Xinle Tang, Hui Xu, Wei Xiong, Yanying Guo · 2023 · Scientific Reports
52. Air pollution, life’s essential 8, and risk of severe non-alcoholic fatty liver disease among individuals with type 2 diabetes
    Ruxianguli Aimuzi, Zhilan Xie, Yimin Qu, Yu Jiang · 2024 · BMC Public Health
53. Correlation between T-Lymphocyte Subsets, Regulatory T Cells, and Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver
    Xia Wang, Weiqin Li, Jiangfeng Fu, Yaping Ni, Kaige Liu · 2022 · Evidence-based Complementary and Alternative Medicine · Retracted
54. Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and Targets
    Daniel F. Schwarz, Maxime Le Marois, Volker Jörg Friedrich Sturm, Andreas Sebastian Peters, Rémi Longuespée, Dominic Helm, Martin A. Schneider, Bastian Eichmüller, Åsa S. Hidmark, Manuel Dominik Fischer et al. · 2024 · Diabetes
55. Vitamin D Attenuates Hepatic Sinusoidal Capillarization in Type 2 Diabetes Mellitus– Metabolic Dysfunction-Associated Fatty Liver Disease via Dual Autophagy Activation and Pyroptosis Suppression in Liver Sinusoidal Endothelial Cells
    Panpan Jiang, Yang Liu, Juxiang Liu, Jinxing Quan · 2025 · Biomedicines
56. Fetuin-A as a Link Between Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes: A Metabolic Insight for Clinical Practice
    Oana Irina Gavril, Cristina Andreea Adam, Theodor-Constantin Stamate, Radu Sebastian Gavril, Ioana Mădălina Zota, Alexandru Raul Jigoranu, Andrei Drugescu, Alexandru Dan Costache, Irina Eşanu, Lidia Iuliana Arhire et al. · 2025 · Biomedicines
57. Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver disease
    Jingyang Zhu, Mei Tang, Hu Li, Yulong Shi, Yiming Li, Yinghong Li, Xican Ma, Qionglu Duan, Yuheng Mei, Hongwei He et al. · 2023 · Bioorganic Chemistry
58. Association between the traditional Chinese medicine constitution and metabolic dysfunction-associated fatty liver disease in older people: A cross-sectional study
    Tianran Shen, Shupei Wang, Zhihao Wang, Hanlu Jia, Yuan Wei, Yu Li, Qiutong Zheng, Yuting Li, Luanzhao Pan, Qingsong Chen · 2024 · Heliyon
59. GBA3 promotes fatty acid oxidation and alleviates non-alcoholic fatty liver by increasing CPT2 transcription
    Juyi Li, Yingqun Ni, Yuanyuan Zhang, Huaizhen Liu · 2024 · Aging
60. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
    Lucy Gracen, Kelly Lee Hayward, Melanie Aikebuse, Anthony William Russell, James P. O’Beirne, Steven McPhail, Katharine M. Irvine, Suzanne Williams, Patricia Casarolli Valery, Elizabeth Ellen Powell · 2022 · BMC Health Services Research
61. Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
    Yana V. Kiseleva, Roman Vyacheslavovich Maslennikov, A. N. Gadzhiakhmedova, Tatyana S. Zharikova, Dmitry Valerievich Kalinin, Yury O Zharikov · 2023 · World Journal of Hepatology
62. Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies
    Sathish Kumar Mungamuri, Yogendra Kumar Gupta, Padaki Nagaraja Rao, Bagepally Ravishankar · 2023 · Gene Expression
63. Protective role of sulforaphane in lipid metabolism-related diseases
    Lingfeng Zhao, Jiahuan Li, Yiping Dang, David P. Fisher, Nguyễn Thị Thu Hiền, Erkin Isakovich Musabaev, Khrystyna Pronyuk, Lei Zhao · 2025 · Molecular Biology Reports
64. PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetes
    Kalliopi Pafili, Oana‐Patricia Zaharia, Klaus Straßburger, Birgit Knebel, Christian Herder, Maximilian Huttasch, Yanislava Karusheva, Stefan Kabisch, Alexander Strom, Bettina Nowotny et al. · 2025 · Clinical Nutrition
65. Screening for the Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Among Patients With Prediabetes and Type 2 Diabetes: A Comparison of Three Screening Systems
    Ruba Alhabahbeh, Ala’eddien Obeidat, Dunia S Jaber, Mohammed M. AlKhaldi, Lara Ghanem, Ahmad A. Toubasi, Zaina N. Obeidat, Hussam H. Alhawari · 2025 · International Journal of Endocrinology
66. miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future
    Roxana Liana Lucaciu, Olga Hilda Orasan, Adriana Corina Hangan, Mihaela Iancu, Angela Cozma, Sorina Cezara Coste, Sidonia Gog-Bogdan, Bogdan Sevastre, Lucia Maria Procopciuc · 2025 · International Journal of Molecular Sciences
67. Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
    Xiaoting Lu, Yong‐Dong Wang, Ting-Ting Zhu, Huilian Zhu, Zhao-Yan Liu · 2022 · Frontiers in Nutrition
68. Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
    Muhammed Mubarak · 2024 · World Journal of Gastrointestinal Pathophysiology
69. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review
    Zhaolin Sun, Yuhua Wei, Yuchen Xu, Jianwei Jiao, Xiuying Duan · 2024 · Pharmacological Research - Modern Chinese Medicine
70. Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice
    Lijuan Liu, Weiming Sun, Xulei Tang, Donghu Zhen, Conghui Guan, Songbo Fu, Jinjin Liu · 2024 · Molecular and Cellular Endocrinology
71. Possible protective effect of natural flavanone naringenin-reduced graphene oxide nanosheets on nonalcoholic fatty liver disease
    Doaa Abdelmoneim, Ehab Eldomany, Mohamed El‐Adl, Ahmed A. Farghali, Gehad El‐Sayed, El Said El Shirbini El Said · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
72. Grape‐Seed Proanthocyanidin Extract (GSPE) Modulates Diurnal Rhythms of Hepatic Metabolic Genes and Metabolites, and Reduces Lipid Deposition in Cafeteria‐Fed Rats in a Time‐of‐Day‐Dependent Manner
    Romina M. Rodríguez, Leonardo Vinícius Monteiro de Assis, Enrique Calvo, Marina Colom‐Pellicer, Sergio Quesada‐Vázquez, Álvaro Cruz‐Carrión, Xavier Escoté, Henrik Oster, Gerard Aragonès, Miquel Mulero · 2024 · Molecular Nutrition & Food Research
73. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
    Sayali Bhave, Han Kiat Ho · 2021 · Biomedicines
74. Association between Dietary Pattern, Nutritional Status, Metabolic Factors, and Nonalcoholic Fatty Liver Disease
    Guisheng Xing, Ying Huang, Xiao Liu · 2022 · Contrast Media & Molecular Imaging
75. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease
    Amir Avan, Ghazaleh Pourali, Zeinab Sadat Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour‐Mobarhan, Gordon A. Ferns et al. · 2023 · Current Drug Targets
76. Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes
    Kálmán Benedikt Bódis, Maria Bombrich, Martin Schön, Birgit Knebel, Oana‐Patricia Zaharia, Gidon Josia Bönhof, Yanislava Karusheva, Klaus Straßburger, Yuliya Kupriyanova, Jörg Kotzka et al. · 2023 · Nutrition Metabolism and Cardiovascular Diseases
77. GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
    Haoran Jiang, Linquan Zang · 2024 · Current Pharmaceutical Design
78. Milk thistle protects against non-alcoholic fatty liver disease induced by dietary thermally oxidized tallow
    Neelab Neelab, Alam Zeb, Muhammad Abdullah Jamil · 2024 · Heliyon
79. Alleviation of metabolic dysfunction–associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy 1
    Ming-qiang Liu, Yuan Wu, Ye Li, Yan-bo Wei, Ling‐yue Dong, Wei An · 2025 · Journal of Pharmacology and Experimental Therapeutics
80. D-Psicose mitigates NAFLD mice induced by a high-fat diet by reducing lipid accumulation, inflammation, and oxidative stress
    Jiajun Tan, Wen Sun, Xueyun Dong, Jiayuan He, Asmaa Mohamed Mahmoud Ali, Min Chen, Leilei Zhang, Liang Wu, Keke Shao · 2025 · Frontiers in Nutrition
81. High-fat diet mediates the formation of nonalcoholic fatty liver by modulating the AhR/miR-132/SIRT1 axis
    Qing Tao, Jing Xie, Yuanzhi Zhou, Yongkang Wu, Hongdeng Xia, Jingjing Wang, Chunwei Zhang, Chengyan Wei, Yong Jie Jin · 2025 · The Journal of Nutritional Biochemistry
82. Exosome-based liquid biopsy for rare and complex diseases
    Jiale Li, Jun Peng, Haijun Guo, Wei Zheng, Rui Chen, Changfeng Miao, Jiachong Wang, Zigui Chen, Chunhai Tang · 2025 · International Journal of Surgery
83. Epigenetic regulation in type II diabetes: linking molecular mechanisms to clinical management
    Maryam Chaudhry, Saı̈d Sif · 2026 · Journal of Diabetes & Metabolic Disorders
84. Integrative Transcriptomics and Proteomics Analysis Reveals THRSP’s Role in Lipid Metabolism
    Yujie Li, Ke Xu, Ao Zhou, Zhong Xu, Junjing Wu, Xianwen Peng, Shuqi Mei, Hongbo Chen · 2024 · Genes
85. Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice
    Sangam Rajak, Archana Tewari, Sana Raza, Pratima Gupta, Bandana Chakravarti, Baby Anjum, Madhulika Tripathi, Brijesh Kumar Singh, Paul M. Yen, Amit Goel et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
86. CXCL6 promotes the progression of NAFLD through regulation of PPARα
    Yanli Zou, Ting Zhan, Jiaxi Liu, Jie Tan, Weijie Liu, Shasha Huang, Yisan cai, Xiaodong Huang, Xiaodong Huang, Tian Xia · 2023 · Cytokine
87. Kaempferol Improves Cardiolipin and ATP in Hepatic Cells: A Cellular Model Perspective in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Akiko Sakurai, Toshihiro Sakurai, Hsin‐Jung Ho, Hitoshi Chiba, Shu‐Ping Hui · 2024 · Nutrients
88. Alterations of Liver Functions and Morphology in a Rat Model of Prediabetes After a Short-term Treatment of a High-fat High-glucose and Low-dose Streptozotocin
    Desak Gede Budi Krisnamurti, Erni Hernawati Purwaningsih, Tri Juli Edi Tarigan, Christian Marco Hadi Nugroho, Vivian Soetikno, Melva Louisa · 2022 · Open Access Macedonian Journal of Medical Sciences
89. The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease
    Dandan Qin, Pingping Huang, Jialing Chen, Changjun Wu, Yi Liang · 2025 · Frontiers in Endocrinology
90. Gut microbiota-based metabolism contributes to the protection of pseudolaric acid B against MAFLD
    Tingyu Song, Xiufang Yang, Junyi Wang, Lianhong Yin, Xuerong Zhao, Ning Wang, Youwei Xu, Yan Qi, Cun-quan Xiong, Lina Xu · 2025 · Phytomedicine
91. Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives
    Jin Jin, C Chia-Kai Yang · 2026 · Metabolites
92. The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014
    Ruli Wang, Ningxi Wu, Huan Qu, Xiaowei Zheng, Haoyang Zhang, Lihong Zhu, Xiaolei Wang, Xiaodie Yao, Le Zhang · 2025 · Frontiers in Endocrinology
93. Association Between Alpha-1-Acid Glycoprotein and Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Adult Women
    Yansong Fu, Siyi Zhang, Xin Zeng, Hong Qin · 2025 · Metabolites
94. Hepatocyte-Specific Casein Kinase 1 Epsilon Ablation Ameliorates Metabolic Dysfunction–Associated Steatohepatitis by Up-Regulating Tumor Necrosis Factor Receptor–Associated Factor 3 in Mice
    Mwense Leya, Hyuneui Jeong, Daram Yang, Tien Huyen Ton Nu Bao, Prakash Raj Pandeya, Sang-Ik Oh, Yoon‐Seok Roh, Jong-Won Kim, Bumseok Kim · 2024 · American Journal Of Pathology
95. Polygala tenuifolia Willd. Extract delays non-alcoholic fatty liver disease progression in rats via the COX2 and PERK-elF2α-ATF4 pathway
    Zhi‐Liang Sun, Zhongshi Zhou, Kezheng Liao, Yanju Liu, Yanyun Liu, Chaoyang Wang, Zhihua Zhang, Li Wen · 2025 · Frontiers in Pharmacology
96. Effect of Flutriafol Exposure on Residue Characteristics in Pig Muscle and Fat Tissue
    Jin Young Jeong, Byeonghyeon Kim, Sang Yun Ji, Youl-Chang Baek, Min‐Ji Kim, Seol Hwa Park, Hyun-Jung Jung · 2021 · Food Science of Animal Resources
97. Lifestyle-Related Diseases and Metabolic Syndrome
    Naofumi Shiomi · 2022 · IntechOpen eBooks
98. PRDX2 deficiency increases MCD-induced nonalcoholic steatohepatitis in female mice
    Mengqi Zhang, Xiaofeng Shi, Minglei Tang, Wen Yin, Cheng Luo, Xiangyang Xie · 2024 · Biochemical and Biophysical Research Communications
99. WITHDRAWN: Ip3r-Grp75-Vdac and Relevant Ca2+ Signaling Regulate Dietary Palmitic Acid-Induced De Novo Lipogenesis by Mitochondria-Associated ER Membrane (MAM) Recruiting Seipin in Yellow Catfish
    Yu–Feng Song, Zhen-Yu Bai, Xiao‐Hong Lai, Zhi Luo, Christer Högstrand · 2024 · Journal of Nutrition · Retracted
100. A comprehensive framework for managing metabolic dysfunction-associated steatotic liver disease: analyzing novel risk factors and advances in nanotechnology-based treatments and diagnosis
     Lucia M. Chávez-López, Gabriela I. Carballo-López, K. C. Lugo-Ibarra, Ana Bertha Castro-Ceseña · 2024 · RSC Medicinal Chemistry